深圳济康医药科技

Shenzhen Jikang Pharmaceutical Technology Co., Ltd. is a pharmaceutical research and development company based in Shenzhen, China, specializing in high-end generic drugs and improved new drugs. Founded in 2016, the company focuses on advanced drug delivery systems (DDS), including sustained-release, controlled-release, and complex injectable formulations. Their product portfolio primarily targets cardiovascular, hematological, and neurological conditions, with a focus on anticoagulants and treatments for chronic diseases. Jikang operates as a technology-driven enterprise, providing R&D services, technology transfer, and registration support to pharmaceutical manufacturers. The company is recognized as a National High-tech Enterprise, reflecting its commitment to innovation in pharmaceutical formulation and process development.